---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-015041"
form_type: "8-K"
ticker: "ZVSA"
cik: "0001859007"
company_name: "ZyVersa Therapeutics, Inc."
filed_at: "2024-04-17T23:59:59+00:00"
generated_at: "2026-06-03T21:51:29.316639+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# ZyVersa shareholders approve reverse stock split; board sets 1-for-10 ratio

## Summary
- Shareholders approved reverse stock split at special meeting on April 17, 2024, with 2,058,182 votes for and 899,831 against.
- Board of directors subsequently authorized a 1-for-10 reverse stock split ratio.
- Reverse stock split effective at 4:01 p.m. ET on April 25, 2024; post-split trading begins April 26, 2024.
- New CUSIP number for common stock after reverse split: 98987D 300.

## SEC filing metadata
- accession: 0001493152-24-015041
- form_type: 8-K
- ticker: ZVSA
- cik: 0001859007
- company_name: ZyVersa Therapeutics, Inc.
- filed_at: 2024-04-17T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.07, 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1859007/000149315224015041/0001493152-24-015041-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1859007/000149315224015041/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-015041
- JSON: https://secwatch.observer/filing/0001493152-24-015041.json
- Plain text: https://secwatch.observer/filing/0001493152-24-015041.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.